We track fresh interviews on the most reputable financial channels — CNBC,
Bloomberg, Yahoo Finance, Schwab Network and more — and use AI to distil what
top fund managers, strategists and economists are actually positioning for.
19
People recognized
33
Interviews summarized
51
Trusted sources
2026-06-22
Latest interview
Informational only, not investment advice. Each summary is an
AI-generated paraphrase of a public interview, attributed to the speaker and linked to
the original video. We don't reproduce transcripts. Always do your own research and
consult a licensed advisor before making investment decisions.
The Consensus Right Now
risk on
The panel largely leans risk‑on, with a consensus that AI‑driven sectors—especially semiconductors, space‑tech, and infrastructure—are poised for continued upside. While several voices caution against over‑crowding and regulatory capture, they still see strong catalysts such as chip demand, peptide therapy adoption, and strategic buy‑backs. Contrarian investors highlight biotech and other out‑of‑favor areas that have rebounded via takeover activity, adding depth to the bullish stance.
Disagreements arise over the breadth of AI exposure: some warn of a bubble and prefer selective bets, while others remain confident in the long‑term trajectory. Energy markets are split between defensive inventory holding and selective exposure to oil‑linked equities, reflecting differing views on supply‑side risks. Crypto remains largely neutral, with Bitcoin seen as a niche hedge rather than a core holding.
Overall, the consensus is that growth‑oriented equities—especially those tied to AI, space, and infrastructure—offer the most attractive risk‑return profile, while caution is advised on over‑crowded bets, regulatory risks, and certain consumer‑centric sectors.
Broad AI funding amid high ratesLuxury & auto sectors exposed to weak Chinese dataOver‑crowded index betsBitcoinRegulatory capture risks
Equitiesrisk on
Bullish on AI, semiconductors, space, infrastructure, and contrarian biotech, but selective on over‑crowded bets
Cryptoneutral
Bitcoin seen as a niche hedge, not a core holding
Who's saying what
Tiffany Wade · Columbia Threadneedle — Bullish on semiconductor rebound driven by AI infrastructure
David Rosenberg · Rosenberg Research — Bullish on peptide therapies as injection adoption rises
Seth Klarman · Baupost Group — Contrarian focus on out‑of‑favor biotech showing takeover activity
Chamath Palihapitiya · Social Capital — Bullish on AI but warns of regulatory risk and fragmentation
Anastasia Amoroso · Partners Group USA — Defensive stance on energy, holding oil inventories as hedge
Vicki Chee · Ruby Co — Selective AI exposure, cautious on broader funding amid rates
Colin Smith · Maggi Investment Management — Selective equities in energy‑linked stocks, cautious on luxury/auto
Rick Readers · BlackRock — Bullish on SpaceX IPO as medium‑term addition
Lincoln Pan · Jardine Matheson Holdings — Bullish on infrastructure, engineering, overseas deals with dividend target
Philippe Laffont · Coatue Management — AI exposure but cautious on bubble, neutral on Bitcoin
Key disagreements:Some view AI as a bubble and prefer selective bets; others remain bullishEnergy markets split between defensive inventory holding and selective exposureRegulatory capture could stifle AI competition
Synthesized from 19 recognized voices over the last 14 days
· updated 2026-06-22
Tech and AI‑related chips set for another quarter‑long rally
Tiffany Wade says the recent pull‑back in semiconductor stocks was brief and that the sector is back in gear, driven by sustained AI‑infrastructure spending. She expects chip makers to keep delivering revenue and earnings upgrades for the next few quarters, with demand from hyperscalers and new memory deals reinforcing the upside. Wade also flags Micron’s upcoming earnings as a key catalyst to confirm the trend.
David Rosenberg· Rosenberg ResearchStrategistrisk on
2026-06-21
Self‑injection comfort set to boost peptide market
David Rosenberg points out that the once‑significant reluctance to self‑inject has waned, driven by widespread use of GLP‑1 drugs and the normalization of med‑spa injections. He argues this reduced barrier will likely spur faster adoption of other peptide therapies, expanding the addressable market. Consequently, he sees a growing opportunity for peptide‑related products and services.
Contrarian bias toward overlooked sectors like biotech
Klarman advises young investors to seek firms where they would want their own capital, emphasizing patience and mentorship. He cites biotech as an example of a sector that was deeply out of favor two years ago but has since rallied with strong takeover activity. His view suggests a preference for contrarian, out‑of‑favor areas that show signs of fundamental improvement rather than chasing already hot trends.
Chamath warned that the Anthropic‑Fable episode highlights the risk of a few hyperscalers monopolising AI infrastructure. He argued that market forces will push the AI stack toward fragmentation and open‑source alternatives, which he sees as a long‑term positive for investors. While he remains bullish on the AI sector overall, he cautions against regulatory capture that could stifle competition.
Anastasia Amoroso says Partners Group entered the recent oil supply outage with substantial inventories, enough to cover about 200 days of net imports. She views this buffer as providing a cushion that likely prevented a recession, indicating a defensive stance toward energy markets. Her comments suggest the firm is holding oil inventories as a hedge against supply disruptions rather than actively trading for price appreciation.
Long on memory and CPU chips amid supply shortages
Vicki says the Asian equity portfolio is tilted toward semiconductor sub‑sectors where supply constraints are creating pricing power, especially memory and CPUs. She remains cautious on broader AI funding, which is feeling the drag of higher rates, and prefers to stay selective rather than broad market exposure.
▲ Memory chipslong
▲ CPU manufacturerslong
▼ AI‑related equity fundingavoid
Europe steady, look to emerging‑market equity winners
Smith says the reopening of the Strait of Hormuz and the easing of Middle‑East tensions should channel capital back into Europe, but he expects the real upside in selective equities rather than a broad rally. He is favouring emerging‑market importers of oil and energy‑linked stocks, especially India, and is cautious on Europe’s luxury and auto sectors that remain exposed to weak Chinese consumer data.
▼ European equitiestrim
▲ India equity indexlong
▲ Oil‑importing EM stockslong
Readers said the SpaceX IPO attracted broad retail participation without sparking the expected frenzy, which helped calm the VIX. He views the offering as a catalyst that could unlock further cash flows for investors and sees the equity as an attractive medium‑term addition to portfolios.
Steady buy‑back, dividend lift and selective M&A to close conglomerate discount
Pan said the group is finishing a $250 million buy‑back and will immediately start a $500 million programme, while raising the dividend to sustain a 9 % total‑return target over five years. He highlighted recent asset recycling, a $5 billion divestiture, and a new acquisition of Australia’s largest radiology chain as the engine for future earnings growth. Capital will be steered toward higher‑growth sectors such as infrastructure, engineering and selective overseas deals, with a focus on Australia and a limited number of OECD‑focused acquisitions.
Laffont: Bet on AI, semis, space; shun index crowd
Philippe Laffont says Coatue is heavily weighting AI‑related opportunities, both public semiconductor exposure and private stakes in firms like Anthropic and OpenAI. He also sees long‑term upside in space‑based telecom infrastructure and is willing to hold sizable cash positions to avoid over‑crowded index bets. He remains skeptical of a broad AI bubble and is neutral to short on Bitcoin, viewing it as a niche hedge rather than a core holding.
Terry Smith says Fundsmith reduced its holdings in Microsoft and Alphabet because the companies' annual spending of around $600 billion would require $180 billion of new cash flow to justify a 30% return on capital, which he sees as unlikely without a dominant player emerging. He expresses uncertainty about whether any Western firm can generate the needed returns, leading to a cautious stance on these tech giants.
Davis runs a long‑only, concentrated equity portfolio that treats each holding as a business to be owned forever. He looks for companies with durable competitive advantages, strong cash‑generation, and culture that protects against accounting‑driven earnings manipulation. The fund trades at roughly 14‑15 × earnings, well below the broader market, and is heavily weighted to large‑cap financials, selective growth names, and a handful of non‑financials he believes can compound earnings for decades. He warns against chasing high‑multiple AI/semiconductor momentum and also against sitting in cash, positioning the strategy as a middle‑ground, long‑term value‑growth blend.
Loeb sees short odds in homebuilders, eyes AI upside
Loeb says the fund is actively shorting the home‑building sector, citing over‑leveraged land commitments and price‑cost mismatches. He also flags high‑profile tech stocks such as Nvidia as “safe shorts” given their inflated valuations, while emphasizing a broader shift toward investing in high‑quality, innovative companies—especially those tied to AI and disruptive tech. The overall tone is mixed, balancing bearish bets with a focus on long‑term, quality growth themes.
Pabrai: Double‑down on concentrated, high‑conviction bets
Mohnish Pabrai says he will keep his portfolio heavily weighted to a few ultra‑conviction ideas – notably his Turkish investments, Constellation Software and select coal companies – and let them run for the long term. He argues that micro‑level business quality trumps macro risk, that trimming winners is a mistake, and that a diversified index is only a fallback for investors who cannot hold concentrated positions.
Robbins: favor distressed health stocks, AI chips, and payment processors
Robbins says Glenview is buying stocks that have fallen but have solid fundamentals, such as CVS Health, Teva, Viatris and Tenet Healthcare, while also staying long on high‑growth AI‑related semiconductor names like AMD and AMAT. He highlights Global Payments and Genius Sports as attractive, cash‑generating plays and notes that leverage reductions and buy‑backs make the valuations compelling.
Summaries are AI-generated paraphrases of publicly available interviews, provided for
informational purposes only and attributed to the original video. They are not, and should
not be relied upon as, investment advice or a recommendation to buy or sell any security.
We do not reproduce interview transcripts. Always do your own research.
Frequently asked questions
What are top hedge fund managers saying about the market right now?
We track recent interviews of leading fund managers and summarize each
one's current market positioning — what they favor, avoid, are buying or selling — plus an
aggregated consensus across them, updated continuously.
How are these manager summaries created?
Each summary is an AI-generated paraphrase of a public interview from a
reputable channel, attributed to the speaker and linked to the original video. It is
informational reporting, not investment advice.
Is this investment advice?
No. These are short, AI-generated paraphrases of what managers said
publicly, provided for informational purposes only. Always do your own research and consult
a licensed advisor before investing.
👋
Welcome to 13Foresight!
We track 13F filings from thousands of hedge funds and alert you when your followed funds file new positions.